These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 81103)

  • 21. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparison of methods for determination of humoral and cell-mediated immunity in patients with breast cancer.
    Nedbalová M; Trojan S; Dohnalová A; Jandová A
    Electromagn Biol Med; 2009; 28(3):233-9. PubMed ID: 20001700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of leukocyte subpopulations in the indirect leukocyte adherence inhibition assay in the mammary tumor virus system.
    Creemers P
    Eur J Immunol; 1977 Jan; 7(1):48-53. PubMed ID: 191259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
    Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LAI reactivity in rats immunized with tumor cells.
    Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
    Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
    Zöller M; Matzku S; Schulz U; Price MR
    J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test.
    Kalafut F; Hung PM; Novotná L; Grófová M
    Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice.
    Tagliabue A; Herberman RB; Arthur LO; McCoy JL
    Cancer Res; 1979 Jan; 39(1):35-41. PubMed ID: 83909
    [No Abstract]   [Full Text] [Related]  

  • 34. Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells.
    Yang NS; McGrath CM; Furmanski P
    J Natl Cancer Inst; 1978 Nov; 61(5):1205-8. PubMed ID: 81881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM; Grosser N
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract]   [Full Text] [Related]  

  • 36. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of antigens immunologically related to the antigens of the mouse mammary tumor virus in the tissue of human breast tumors].
    Remennik LV; Litvinov SV; Kriukova IN; Chuev IuV
    Biull Eksp Biol Med; 1985 Jun; 99(6):734-6. PubMed ID: 2990606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.